COM:PROTALIX
Protalix Biotherapeutics
- Stock
Last Close
1.66
22/11 21:00
Market Cap
82.11M
Beta: -
Volume Today
545.62K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -27.79M - | -29.94M 7.75% | -27.28M 8.89% | -29.18M 6.94% | -85.28M 192.28% | -26.46M 68.97% | -18.28M 30.92% | -6.52M 64.31% | -27.58M 322.84% | -14.93M 45.88% | 8.31M 155.68% | |
depreciation and amortization | 3.54M - | 3.14M 11.27% | 2.37M 24.52% | 1.98M 16.33% | 1.92M 3.18% | 1.67M 12.97% | 1.62M 3.23% | 1.30M 19.48% | 1.12M 14.13% | 1.09M 2.86% | 1.19M 9.67% | |
deferred income tax | 142K - | 115K 19.01% | 1.56M 1,257.39% | -7.59M 586.29% | 39.35M 618.42% | -64K 100.16% | -68K 6.25% | -522K 667.65% | 813K 255.75% | -3.09M - | ||
stock based compensation | 4.09M - | 1.24M 69.63% | 1.80M 45.09% | 988K 45.17% | 337K 65.89% | 514K 52.52% | 835K 62.45% | 3.13M 274.37% | 2.38M 24.02% | 2.08M 12.21% | 3.45M 65.37% | |
change in working capital | -10.50M - | -5.72M 45.46% | -3.30M 42.29% | 1.12M 133.81% | 29.10M 2,505.46% | 13.53M 53.53% | -6.83M 150.54% | -27.13M 296.93% | 9.90M 136.49% | -12.02M 221.35% | -10.54M 12.28% | |
accounts receivables | 1.90M - | -799K 141.96% | 523K 165.46% | -1.13M 316.63% | 25K 102.21% | -3.10M 12,496% | 188K 106.07% | 2.09M 1,012.23% | -1.03M 149.35% | -1.19M 15.70% | -428K 64.15% | |
inventory | -3.92M - | 1.29M 132.92% | -2.32M 279.53% | 522K 122.54% | -2.59M 595.79% | -736K 71.56% | 414K 156.25% | -4.93M 1,290.10% | -4.87M 1.12% | 1.15M 123.60% | -2.24M 294.87% | |
accounts payables | -1.32M - | 954K 172.16% | -1.87M 296.33% | 2.14M 214.20% | 4.90M 129.17% | -520K 110.61% | 2.14M 512.12% | 1.91M 10.83% | 2.58M 34.75% | -4.80M 286.56% | 5.29M 210.22% | |
other working capital | -7.16M - | -7.17M 0.14% | 362K 105.05% | -411K 213.54% | 26.76M 6,611.92% | 17.88M 33.19% | -9.58M 153.58% | -26.20M 173.54% | 13.23M 150.49% | -7.17M 154.17% | -13.16M 83.69% | |
other non cash items | -137K - | 1.89M 1,479.56% | 569K 69.89% | 581K 2.11% | 4.57M 686.40% | 3.07M 32.83% | 3.37M 9.78% | 3.64M 8.07% | 3.09M 15.13% | -1.23M 139.77% | -638.00K 48.09% | |
net cash provided by operating activities | -30.65M - | -29.28M 4.48% | -24.28M 17.07% | -32.10M 32.18% | -9.99M 68.86% | -7.74M 22.53% | -19.36M 150.04% | -26.11M 34.86% | -10.29M 60.60% | -25M 143.07% | -1.32M 94.73% | |
investments in property plant and equipment | -1.89M - | -785K 58.47% | -464K 40.89% | -849K 82.97% | -971K 14.37% | -686K 29.35% | -627K 8.60% | -655K 4.47% | -1.46M 122.75% | -628K 56.96% | -1.15M 82.96% | |
acquisitions net | 53K - | 15.42M - | ||||||||||
purchases of investments | -212K - | -90K 57.55% | -20M - | -37.84M 89.18% | -16M 57.71% | -20.42M 27.63% | ||||||
sales maturities of investments | 57.84M - | 11M 80.98% | 5M 54.55% | |||||||||
other investing activites | -126K - | 39.85M 31,727.78% | -118K 100.30% | -148K 25.42% | 95K 164.19% | -256K 369.47% | 703K 374.61% | 327K 53.49% | 593K 81.35% | -15.56M 2,724.28% | ||
net cash used for investing activites | -2.10M - | -1.00M 52.38% | 39.39M 4,034.77% | -967K 102.46% | -1.12M 15.72% | -591K 47.18% | -883K 49.41% | -19.95M 2,159.57% | 18.92M 194.83% | -5.04M 126.61% | -16.71M 231.90% | |
debt repayment | -10.96M - | -4.75M 56.65% | -215K - | -34.12M 15,770.70% | ||||||||
common stock issued | 6.10M - | 46.21M - | 46.20M 0.02% | 8.24M 82.17% | 24.67M 199.49% | |||||||
common stock repurchased | ||||||||||||
dividends paid | ||||||||||||
other financing activites | 66.89M - | 46K 99.93% | 534K 1,060.87% | 19.70M 3,588.20% | 9.54M 51.55% | 472K - | 2K - | |||||
net cash used provided by financing activities | 66.89M - | 46K 99.93% | 6.63M 14,323.91% | 19.70M 196.83% | -1.42M 107.20% | -4.75M 234.88% | 46.47M - | 12.08M 74.01% | 8.24M 31.79% | 24.67M 199.42% | ||
effect of forex changes on cash | 226K - | -1.40M 717.26% | -131K 90.61% | 277K 311.45% | 414K 49.46% | -270K 165.22% | 225K 183.33% | 64K 71.56% | 6K 90.63% | -77K 1,383.33% | -114K 48.05% | |
net change in cash | 34.36M - | -31.63M 192.05% | 21.61M 168.31% | -13.09M 160.60% | -12.12M 7.45% | -13.36M 10.21% | -20.02M 49.88% | 473K 102.36% | 20.72M 4,280.55% | -21.87M 205.57% | 6.52M 129.82% | |
cash at beginning of period | 52.03M - | 86.40M 66.04% | 54.77M 36.61% | 76.37M 39.45% | 63.28M 17.14% | 51.16M 19.15% | 37.81M 26.10% | 17.79M 52.94% | 18.27M 2.66% | 38.98M 113.44% | 17.11M 56.11% | |
cash at end of period | 86.40M - | 54.77M 36.61% | 76.37M 39.45% | 63.28M 17.14% | 51.16M 19.15% | 37.81M 26.10% | 17.79M 52.94% | 18.27M 2.66% | 38.98M 113.44% | 17.11M 56.11% | 23.63M 38.12% | |
operating cash flow | -30.65M - | -29.28M 4.48% | -24.28M 17.07% | -32.10M 32.18% | -9.99M 68.86% | -7.74M 22.53% | -19.36M 150.04% | -26.11M 34.86% | -10.29M 60.60% | -25M 143.07% | -1.32M 94.73% | |
capital expenditure | -1.89M - | -785K 58.47% | -464K 40.89% | -849K 82.97% | -971K 14.37% | -686K 29.35% | -627K 8.60% | -655K 4.47% | -1.46M 122.75% | -628K 56.96% | -1.15M 82.96% | |
free cash flow | -32.54M - | -30.07M 7.61% | -24.75M 17.69% | -32.95M 33.13% | -10.96M 66.72% | -8.43M 23.14% | -19.98M 137.13% | -26.76M 33.91% | -11.74M 56.12% | -25.63M 118.22% | -2.47M 90.37% |
All numbers in USD (except ratios and percentages)